Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | ADH1B | P00325 | 2/20 | 0.50 |
| ▸ | ADH1C | P00326 | 2/20 | 0.50 |
| ▸ | ADH1A | P07327 | 2/20 | 0.50 |
| ▸ | ADH7 | P40394 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27481446 | 1.00 | TSHR (0.73) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL10045094 | 1.00 | TSHR (0.73) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL5323389 | 1.00 | TSHR (0.73) | TSHRALDH1A1CYP2C19MEN1GLA | |
| Hydrochloric Acid SCHEMBL8024908 | 0.96 | TSHR (0.69) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL14782578 | 0.96 | TSHR (0.69) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL2532 | 0.96 | — | — | |
| SCHEMBL27946380 | 0.96 | TSHR (0.79) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL8010480 | 0.93 | TSHR (0.75) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL16926434 | 0.93 | TSHR (0.87) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL6733972 | 0.93 | TSHR (0.65) | TSHRALDH1A1CYP2C19MEN1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11344866-B2 | Method for activating hydrotreating catalysts | ARKEMA FRANCE (FR) | 2022-05-31 | — | — | US | claimed |
| US-20170120230-A1 | METHOD FOR ACTIVATING HYDROTREATING CATALYSTS | ARKEMA FRANCE (FR) | 2017-05-04 | — | — | US | claimed |
| EP-3157677-A1 | METHOD FOR ACTIVATING HYDROTREATING CATALYSTS | Arkema France (FR) | 2017-04-26 | — | — | EP | claimed |
| EP-1370563-B1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NAT RECH SCIENT (FR) | 2006-09-06 | — | — | EP | claimed |
| EP-1370563-A1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2003-12-17 | — | — | EP | claimed |
| WO-2002076991-A1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2002-10-03 | — | — | WO | claimed |
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | ADEKA CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20250343042-A1 | DIFFUSING AGENT COMPOSITION, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE | TOKYO OHKA KOGYO CO LTD (JP) | 2025-11-06 | — | — | US | disclosed |
| US-20250163281-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | ADEKA CORPORATION (JP) | 2025-05-22 | — | — | US | disclosed |
| EP-4484465-A1 | THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME | ADEKA CORPORATION (JP) | 2025-01-01 | — | — | EP | disclosed |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | RECODE THERAPEUTICS, INC. | 2024-07-04 | — | — | US | disclosed |
| WO-2023238799-A1 | DIFFUSING AGENT COMPOSITION, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE | 東京応化工業株式会社 | 2023-12-14 | — | — | WO | disclosed |
| US-11773287-B2 | Method for forming coating | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-10-03 | — | — | US | disclosed |
| US-5153208-A | Influence metabolism of collagen or biosynthesis of c/q/ | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-06 | — | — | US | disclosed |
| US-5037839-A | Hydroxylase enzyme inhibitors, influencing the metabolism of collagen and biosynthesis of c1q | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-08-06 | — | — | US | disclosed |
| US-4918186-A | Process for producing cyclic ureas | MITSUI TOATSU CHEMICALS, INC. (JP) | 1990-04-17 | — | — | US | disclosed |
| US-4900820-A | REACTING UREA WITH ACYCLIC DIAMINE | MITSUI TOATSU CHEMICALS, INC. (JP) | 1990-02-13 | — | — | US | disclosed |
| EP-0249136-A2 | Process for producing cyclic ureas | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1987-12-16 | — | — | EP | disclosed |
| EP-0248220-A2 | Process for producing cyclic ureas | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1987-12-09 | — | — | EP | disclosed |
| US-4179469-A | Preparation of amines | UOP INC. (US) | 1979-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | SORD, SUCLA2, SUCLG1 | TSHR 4867/4885ALDH1A1 196/4885CYP2C19 4010/4885 |
| US-20240216290-A1 | LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF | LIPA, NPC1L1, NPC1 | TSHR 3323/4885ALDH1A1 3082/4885CYP2C19 3232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.